Condition: Fragility Fracture · Hip Fractures · Osteoporosis · Sponsor: AgNovos Healthcare, LLC
A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.
This description comes directly from the study's public registry record.
Charles Raymond · 240-753-6421 · restore@agnovos.com
Always discuss trial participation with your own doctor first.
| Innsbruck Hospital | Innsbruck, Austria | Recruiting |
| Ziekenhuis Oost-Limburg | Genk, Belgium | Recruiting |
| Ghent University Hospital | Ghent, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| Vitaz Sint-Niklaas | Sint-Niklaas, Belgium | Recruiting |
| Health Sciences Centre - Eastern Health | St. John's, Newfoundland and Labrador, Canada | Withdrawn |
| QEII Health Sciences Centre | Halifax, Nova Scotia, Canada | Recruiting |
| Sunnybrook Health Sciences Centre | North York, Ontario, Canada | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| CHU de Nice | Nice, Provence-Alpes-Côte d'Azur Region, France | Recruiting |
| CHU Amiens | Amiens, France | Recruiting |
| CHU Grenoble-Alpes | Grenoble, France | Recruiting |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04796350